Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes- 7 Odd Apparatuses to Make Your Party Stick Out!
- FDA approves Wegovy pill for weight loss
- Greenland’s melting ice and landslide-prone fjords make the oil and minerals Trump is eyeing dangerous to extract
- 25 Most Beautiful Villages in France You Can Actually Visit
- Giude to Best Web based Learning Stage
- The Benefits of Effective money management for Your Youngsters' Future Monetary Prosperity
- Air Force made critical errors during October 7 massacre, investigator says
- Dirty soda started as a Mormon alternative to booze. Now it's everywhere.
